FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091693485> ?p ?o ?g. }

• W2091693485 endingPage "1924" @default.
• W2091693485 startingPage "1917" @default.
• W2091693485 abstract "The purpose of this work is threefold: (1) to explore biological consequences of the multileaf collimator (MLC) calibration errors in intensity modulated radiotherapy (IMRT) of prostate and head and neck cancers, (2) to determine levels of planning target volume (PTV) and normal tissue under- or overdose flagged with clinically used QA action limits, and (3) to provide biologically based input for MLC QA and IMRT QA action limits.Ten consecutive prostate IMRT cases and ten consecutive head and neck IMRT cases were used. Systematic MLC offsets (i.e., calibration error) were introduced for each control point of the plan separately for X1 and X2 leaf banks. Offsets were from - 2 to 2 mm with a 0.5 mm increment. The modified files were imported into the planning system for forward dose recalculation. The original plan served as the reference. The generalized equivalent uniform dose (gEUD) was used as the biological index for the targets, rectum, parotid glands, brainstem, and spinal cord. Each plan was recalculated on a CT scan of a 27 cm diameter cylindrical phantom with a contoured 0.6 cc ion chamber. Dose to ion chamber and 3D gamma analysis were compared to the reference plan. QA pass criteria: (1) at least 95% of voxels with a dose cutoff of 50% of maximum dose have to pass at 3 mm/3% and (2) dose to chamber within 2% of the reference dose.For prostate cases, differences in PTV and rectum gEUD greater than 2% were identified. However, a larger proportion of plans leading to greater than 2% difference in prostate PTV gEUD passed the ion chamber QA but not 3D gamma QA. A similar trend was found for the rectum gEUD. For head and neck IMRT, the QA pass criteria flagged plans leading to greater than 4% differences in PTV gEUD and greater than 5% differences in the maximum dose to brainstem. If pass criteria were relaxed to 90% for gamma and 3% for ion chamber QA, plans leading to a 5% difference in PTV gEUD and a 5%-8% difference in brainstem maximum dose would likely pass IMRT QA. A larger proportion of head and neck plans with greater than 2% PTV gEUD difference passed 3D gamma QA compared to ion chamber QA.For low modulation plans, there is a better chance to catch MLC calibration errors with 3D gamma QA rather than ion chamber QA. Conversely, for high modulation plans, there is a better chance to catch MLC calibration errors with ion chamber QA rather than with 3D gamma QA. Ion chamber and 3D gamma analysis IMRT QA can detect greater than 2% change in gEUD for PTVs and critical structures for low modulation treatment plans. For high modulation treatment plans, ion chamber and 3D gamma analysis can detect greater than 2% change in gEUD for PTVs and a 5% change in critical structure gEUD since either QA methods passes the QA criteria. For gEUD changes less than those listed above, either QA method has the same proportion of passing rate." @default.
• W2091693485 created "2016-06-24" @default.
• W2091693485 creator A5005053451 @default.
• W2091693485 creator A5012511065 @default.
• W2091693485 creator A5026482089 @default.
• W2091693485 creator A5032912945 @default.
• W2091693485 creator A5080986176 @default.
• W2091693485 creator A5083784503 @default.
• W2091693485 date "2012-03-16" @default.
• W2091693485 modified "2023-10-06" @default.
• W2091693485 title "Biological consequences of MLC calibration errors in IMRT delivery and QA" @default.
• W2091693485 cites W1975962221 @default.
• W2091693485 cites W1988445625 @default.
• W2091693485 cites W2002933631 @default.
• W2091693485 cites W2012457048 @default.
• W2091693485 cites W2012514380 @default.
• W2091693485 cites W2017031751 @default.
• W2091693485 cites W2028604160 @default.
• W2091693485 cites W2030129331 @default.
• W2091693485 cites W2050311003 @default.
• W2091693485 cites W2081224305 @default.
• W2091693485 cites W2083698498 @default.
• W2091693485 cites W2098340619 @default.
• W2091693485 cites W2145170673 @default.
• W2091693485 cites W2166010438 @default.
• W2091693485 doi "https://doi.org/10.1118/1.3692177" @default.
• W2091693485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22482613" @default.
• W2091693485 hasPublicationYear "2012" @default.
• W2091693485 type Work @default.
• W2091693485 sameAs 2091693485 @default.
• W2091693485 citedByCount "19" @default.
• W2091693485 countsByYear W20916934852013 @default.
• W2091693485 countsByYear W20916934852014 @default.
• W2091693485 countsByYear W20916934852015 @default.
• W2091693485 countsByYear W20916934852016 @default.
• W2091693485 countsByYear W20916934852019 @default.
• W2091693485 countsByYear W20916934852020 @default.
• W2091693485 countsByYear W20916934852021 @default.
• W2091693485 crossrefType "journal-article" @default.
• W2091693485 hasAuthorship W2091693485A5005053451 @default.
• W2091693485 hasAuthorship W2091693485A5012511065 @default.
• W2091693485 hasAuthorship W2091693485A5026482089 @default.
• W2091693485 hasAuthorship W2091693485A5032912945 @default.
• W2091693485 hasAuthorship W2091693485A5080986176 @default.
• W2091693485 hasAuthorship W2091693485A5083784503 @default.
• W2091693485 hasConcept C104293457 @default.
• W2091693485 hasConcept C105795698 @default.
• W2091693485 hasConcept C121332964 @default.
• W2091693485 hasConcept C126838900 @default.
• W2091693485 hasConcept C141071460 @default.
• W2091693485 hasConcept C145148216 @default.
• W2091693485 hasConcept C151770136 @default.
• W2091693485 hasConcept C161471255 @default.
• W2091693485 hasConcept C165838908 @default.
• W2091693485 hasConcept C198291218 @default.
• W2091693485 hasConcept C201645570 @default.
• W2091693485 hasConcept C2989005 @default.
• W2091693485 hasConcept C3018411727 @default.
• W2091693485 hasConcept C33923547 @default.
• W2091693485 hasConcept C509974204 @default.
• W2091693485 hasConcept C62520636 @default.
• W2091693485 hasConcept C71924100 @default.
• W2091693485 hasConcept C75088862 @default.
• W2091693485 hasConceptScore W2091693485C104293457 @default.
• W2091693485 hasConceptScore W2091693485C105795698 @default.
• W2091693485 hasConceptScore W2091693485C121332964 @default.
• W2091693485 hasConceptScore W2091693485C126838900 @default.
• W2091693485 hasConceptScore W2091693485C141071460 @default.
• W2091693485 hasConceptScore W2091693485C145148216 @default.
• W2091693485 hasConceptScore W2091693485C151770136 @default.
• W2091693485 hasConceptScore W2091693485C161471255 @default.
• W2091693485 hasConceptScore W2091693485C165838908 @default.
• W2091693485 hasConceptScore W2091693485C198291218 @default.
• W2091693485 hasConceptScore W2091693485C201645570 @default.
• W2091693485 hasConceptScore W2091693485C2989005 @default.
• W2091693485 hasConceptScore W2091693485C3018411727 @default.
• W2091693485 hasConceptScore W2091693485C33923547 @default.
• W2091693485 hasConceptScore W2091693485C509974204 @default.
• W2091693485 hasConceptScore W2091693485C62520636 @default.
• W2091693485 hasConceptScore W2091693485C71924100 @default.
• W2091693485 hasConceptScore W2091693485C75088862 @default.
• W2091693485 hasIssue "4" @default.
• W2091693485 hasLocation W20916934851 @default.
• W2091693485 hasLocation W20916934852 @default.
• W2091693485 hasOpenAccess W2091693485 @default.
• W2091693485 hasPrimaryLocation W20916934851 @default.
• W2091693485 hasRelatedWork W1983813071 @default.
• W2091693485 hasRelatedWork W2001386226 @default.
• W2091693485 hasRelatedWork W2022400887 @default.
• W2091693485 hasRelatedWork W2048513016 @default.
• W2091693485 hasRelatedWork W2062551933 @default.
• W2091693485 hasRelatedWork W2162558591 @default.
• W2091693485 hasRelatedWork W2276029454 @default.
• W2091693485 hasRelatedWork W2515360878 @default.
• W2091693485 hasRelatedWork W4362672532 @default.
• W2091693485 hasRelatedWork W96634849 @default.
• W2091693485 hasVolume "39" @default.
• W2091693485 isParatext "false" @default.

• next